Europe

U.K. genomics projects granted $505M

Friday, August 1, 2014 01:41 PM

Genomics England’s 100,000 Genomes Project has received a package of investment worth more than $505 million. The four year project focuses on new research to decode 100,000 human genomes—a patient’s personal DNA code.

More... »


Report: U.K. dementia diagnosis has increased 62% in seven years

Thursday, July 31, 2014 12:38 PM

According to Health and Social Care Information Center (HSCIC), provisional figures show 344,000 patients in the U.K. had a recorded diagnosis of dementia in 2013-2014. This is a rise from 319,000 in 2012-2013 and from 213,000 in 2006-2007, when the data was first collected.

More... »


Report: Generics increase to more than 75% of all 2013 prescriptions in England, Wales

Monday, July 28, 2014 03:04 PM

Usage of generic medicines in England and Wales increased to more than three-quarters of all NHS prescriptions in 2013, according to the latest figures supplied by the Health and Social Care Information Center (HSCIC).

More... »

ESMO concerned about impact of proposed E.U. data protection regulation on cancer research

Monday, July 28, 2014 03:01 PM

ESMO (the European Society of Medical Oncology) has expressed concern the proposed E.U. General Data Protection Regulation could make cancer research impossible and add a significant burden to both doctors and cancer patients.

More... »

RB to invest $170M to build U.K. R&D center

Monday, July 28, 2014 02:59 PM

RB, a global consumer health and hygiene company formerly called Reckitt Benckiser, will invest $170 millionin its consumer health R&D operations with the creation of a state-of-the-art Center of Scientific Excellence to be based in the U.K.

More... »

Xention awarded $2.4M from Technology Strategy Board for atrial fibrillation medicines

Monday, July 28, 2014 02:56 PM

Xention, a Cambridge-based biopharmaceutical company specializing in the discovery and development of ion channel-modulating drugs, was awarded $2.4 million from the Technology Strategy Board, a U.K. innovation agency, to progress its novel IKAChchannel blockers through preclinical development.

More... »

Accovion continues expansion of European presence

Monday, July 21, 2014 03:14 PM

Germany-based CRO Accovion has expanded its European presence. The company, already active in more than 20 countries, has established a subsidiary in Milan, Italy, naming Verónica de Lázaro country director.

More... »

AstraZeneca reveals designs for new U.K. global R&D center, corporate headquarters

Monday, July 21, 2014 03:03 PM

AstraZeneca revealed its proposed designs for its new global R&D center and corporate headquarters in Cambridge, U.K. The facility, which will be located on the Cambridge Biomedical Campus (CBC), includes the global center, an R&D enabling building and an energy center.

More... »

Seven U.K. research councils collaborate on antimicrobial resistance

Thursday, July 17, 2014 12:50 PM

The Medical Research Council (MRC) will lead an initiative of seven research councils, backed by eight government bodies and the Wellcome Trust, to tackle antimicrobial resistance (AMR) on all fronts. The seven research councils are the Arts and Humanities Research Council, Biotechnology and Biological Sciences Research Council, Economic and Social Research Council, Engineering and Physical Sciences Research Council, MRC, Natural Environment Research Council and Science and Technology Facilities Council.

More... »

Report: U.K. cancer patients face increasing coverage restrictions

Wednesday, July 16, 2014 01:18 PM

New research results quantify the extent to which centralized value assessments by the U.K.’s National Institute for Health and Care Excellence (NICE) lead to coverage denials and patient access restrictions to new drugs and biologics. The analysis, conducted by Context Matters, a healthcare information and data analytics technology platform company, and sponsored by the Pharmaceutical Research and Manufacturers of America (PhRMA), shows use of centralized cost-effectiveness standards by NICE and similar appraisals in other countries limit patients’ access to new cancer treatments, which evolve rapidly and are increasingly personalized. 

More... »

`
CenterWatch Data Library
CWWeekly

January 26

2015 CRO outlook: M&As, IPOs, strategic partnerships and increased eClinical outsourcing expected to continue

IOM, industry stakeholders propose standards, guidelines for open sharing of clinical trial data

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January

All eyes on EMA’s adaptive licensing pilot
Sponsors could offer innovative drugs to patients 8 years sooner

Ice Bucket Challenge a boon for ALS research
Donations soar, but phenomenon difficult to replicate

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

December

Growing adoption of feasibility review committees
Early reports cite fewer amendments, improved cycle time

AMCs vying to better compete for industry trials
Working to conquer study start-up delays, IRB review process

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs